Morgan Stanley analyst maintained a Buy rating on Pharmaron Beijing Co., Ltd. Class H on May 28 and set a price target of HK$31.00. The company...
Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter
Pharmaron Beijing Co., Ltd. Class H has an analyst consensus of Strong Buy, with a price target consensus of €3.19.
17Q1 market cap is currently HK$48.83B and has a P/E ratio of 26.63.
In a report released on May 28, from Morgan Stanley maintained a Buy rating on Keymed Biosciences, Inc., with a price target of…
Morgan Stanley analyst Jack Lu, CFA maintained a Buy rating on Contemporary Amperex Technology Co., Limited Class H on May 28 and…
UBS analyst maintained a Buy rating on China Hongqiao Group Ltd. on May 28 and set a price target of HK$46.10. The company’s…
In a report released yesterday, from Huatai Securities maintained a Buy rating on CSPC Pharmaceutical Group, with a price target…
In a report released yesterday, from J.P. Morgan maintained a Buy rating on MINISO Group Holding Ltd., with a price target of…
UBS analyst maintained a Buy rating on Hangzhou Tigermed Consulting Co., Ltd. Class H on May 28 and set a price target of…
